Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora bought 5,814 shares of the company’s stock in a transaction on Wednesday, May 20th. The shares were bought at an average cost of $4.39 per share, for a total transaction of $25,523.46. Following the transaction, the president owned 15,914 shares in the company, valued at $69,862.46. The trade was a 57.56% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora purchased 6,420 shares of Auna stock. The stock was bought at an average cost of $4.15 per share, with a total value of $26,643.00.
- On Thursday, May 28th, Leon Jesus Zamora acquired 9,220 shares of Auna stock. The shares were bought at an average price of $4.17 per share, with a total value of $38,447.40.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 30,000 shares of Auna stock. The shares were bought at an average cost of $4.39 per share, for a total transaction of $131,700.00.
- On Wednesday, May 27th, Leon Jesus Zamora bought 23,273 shares of Auna stock. The stock was purchased at an average cost of $4.20 per share, for a total transaction of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora bought 8,727 shares of Auna stock. The stock was purchased at an average price of $4.24 per share, with a total value of $37,002.48.
Auna Stock Performance
Shares of AUNA stock opened at $4.52 on Wednesday. The business has a fifty day moving average of $5.20 and a 200 day moving average of $5.01. Auna S.A. has a 1 year low of $4.09 and a 1 year high of $6.85. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The firm has a market capitalization of $334.16 million, a price-to-earnings ratio of 17.37 and a beta of 0.81.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. World Investment Advisors purchased a new stake in Auna in the 4th quarter worth approximately $52,000. Virtu Financial LLC purchased a new position in shares of Auna during the 3rd quarter valued at approximately $75,000. Millennium Management LLC acquired a new position in shares of Auna in the 3rd quarter valued at $83,000. Clear Harbor Asset Management LLC acquired a new position in shares of Auna in the 4th quarter valued at $63,000. Finally, Sanctuary Advisors LLC purchased a new stake in Auna during the first quarter worth $71,000.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of Auna in a report on Friday, March 27th. Wall Street Zen cut shares of Auna from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 16th. JPMorgan Chase & Co. dropped their price objective on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Finally, Zacks Research lowered shares of Auna from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Auna has a consensus rating of “Hold” and an average target price of $6.97.
Get Our Latest Stock Report on Auna
About Auna
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Recommended Stories
- Five stocks we like better than Auna
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
